Patrys Limited

About Patrys Limited

Patrys Limited is a publicly-listed company focused on developing novel antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases. Their mission is to create revolutionary therapies using their proprietary deoxymab platform.

Products & Services

Deoxymab Platform:A proprietary antibody technology targeting DNA processes inside cells and the cell nucleus, capable of crossing the blood-brain barrier, and inhibiting NETosis, which is linked to cancer and inflammatory diseases.

Single Agent Therapies:Therapies to treat diseases caused by NETosis, including certain cancers and inflammatory conditions.

Combination Therapies:Using deoxymabs alongside other therapeutic treatments for enhanced efficacy.

Targeting Agent:Delivers therapeutic payloads directly into the cell nucleus.

Specialties

Antibody Technologies Cancer Treatment NETosis-driven Inflammatory Diseases Deoxymab Platform

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Securities Issue T: - FT: Securities Issue	A: 2217946752 MR: - FA: 2,217,946,752 securities FAN: 2217946752	D: 2025-07-23 FD: 2025-07-23	-
2	RT: Entitlement Offer T: - FT: Entitlement Offer	A: 1770000 MR: - FA: 1.77 million FAN: 1770000	D: 2025-07-23 FD: 2025-07-23	-
3	RT: Entitlement Issue T: - FT: Entitlement Issue	A: 1770000 MR: - FA: 1.77 Million FAN: 1770000	D: 2025-07-23 FD: 2025-07-23	-
4	RT: Securities issue (likely equity raise) T: - FT: Securities issue (likely equity raise)	A: 1030000000 MR: - FA: 1,030,000,000 securities FAN: 1030000000	D: 2025-07-23 FD: 2025-07-23	-

Securities Issue Latest

2025-07-23

$2.2B

Entitlement Offer 2025-07-23

$1.8M

Entitlement Issue 2025-07-23

$1.8M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Peter Christie

Non-Executive Chairman

J

James Campbell

Non-Executive Director

A

Anton Uvarov

Non-Executive Director

V

Valentina Dubljevic

Vice President, Research and Development, MBB, BSc, GAICD

S

Stefan Ross

Company Secretary, BBus (Accounting)

P

Peter Ordentlich

Chief Scientific Officer

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Patrys Limited Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised